Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Social Factors Impact Outcomes in HCM Patients
Added: 3 months ago Source:  Radcliffe Cardiology
While social determinants of health (SDOH) are known to influence outcomes in acquired cardiovascular diseases, their impact on conditions with a strong genetic basis, such as hypertrophic cardiomyopathy (HCM), has been less clear.² A new study using data from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) suggests that area-based social factors are independently associated with adverse… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
Diagnosing Hypertrophic Cardiomyopathy with Dr Sara Saberi
Author(s): Sara Saberi Added: 6 months ago
Master the diagnostic complexities of hypertrophic cardiomyopathy (HCM) with Dr Sara Saberi, a leading expert in inherited cardiovascular diseases.This comprehensive presentation, part of the Cardiomyopathies track of Women As One's CLIMB® 2025 Skills Training Program, provides essential insights into the nuanced approach required for accurate HCM diagnosis and risk stratification.Dr Saberi… View more

Heart Failure
Conduction System Pacing: A Fresh Look
Author(s): Óscar Cano, Marek Jastrzębski, Pugazhendhi Vijayaraman Start date: Nov 13, 2024
Conduction System Pacing: Recent Advances and Clinical ApplicationsConduction system pacing (CSP) has significantly evolved in recent years, expanding from His bundle pacing to include left bundle branch pacing and left ventricular septal pacing. This webinar, led by Dr Pugazhendhi Vijayaraman, a renowned expert in the field, features presentations from esteemed faculty, Prof Marek Jastrzębski… View more

Electrophysiology & Arrhythmia

Heart Failure
Iron Deficiency in LVAD Patients
Author(s): William Herrik Nielsen , Finn Gustafsson Added: 1 year ago

Heart Failure
Cardiac PET/MRI and Doxorubicin Cardiotoxicity
Author(s): Jun Hua Chong , Stephanie Marchesseau , Jennifer A Bryant , et al Added: 5 months ago

Heart Failure
Recovery of Anthracycline-Induced Cardiomyopathy
Author(s): Joe Carver, Osnat Itzhaki Ben Zadok, Jose Alvarez-Cardona Start date: Nov 06, 2025
Join Dr Joe Carver (University of Pennsylvania, US), Dr Osnat Itzhaki Ben Zadok (Rabin Medical Center, IL) and Dr Jose Álvarez Cardona (New York University School of Medicine, US) for this month's Journal Club where they will discuss pathways to cardiac recovery after anthracycline-induced cardiomyopathy.The partnership combines Radcliffe’s rapidly growing global community and expertise in… View more

CV Disease in Special Populations

Heart Failure
Prognostic Value of HF Stratification and Cardiologist Follow-Up
Author(s): Guillaume Baudry Added: 11 months ago
ESC HF 25 - Findings from a French nationwide cohort study investigating cardiologist follow-up show greater reduction in all-cause mortality associated with annual cardiology hospital visits.Dr Guillaume Baudry (University Hospital of Brabois, Nancy, FR) discusses findings from a nationwide trial investigating the prognostic value of heart failure stratification and cardiologist follow-up in… View more

Heart Failure
Start date: Sep 01, 2024 End date: Sep 01, 2024
Radcliffe Medical Education is hosting a symposium entitled 'The Bigger Picture: An Expert Assessment on the True Impact of ATTR-CM' at 12:30 UCT+1 on Sunday 1 September 2024 in the Prague Room atESC 2024, ExCel Centre, London, UK.OverviewProf Julian Gillmore (University College London, London, UK) will lead a distinguished faculty in an upcoming CME-accredited session. The faculty includes Dr… View more

Heart Failure
Job title: Interventional Cardiologist
Dr Guilherme Attizzani is an Interventional Cardiologist at University Hospitals in Cleveland, OH. He specializes in structural heart disease and complex coronary interventions, with extensive experience in transcatheter aortic valve replacement (TAVR) and Redo TAV procedures. Dr. Attizzani has contributed to numerous clinical trials and registries focused on advancing outcomes in structural… View more
ACC 24 Late-Breaker Discussion: The ARISE-HF Trial
Author(s): Harriette Van Spall , James L Januzzi Added: 2 years ago
ACC 2024 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) sits down with Dr James L. Januzzi (Massachusetts General Hospital & Harvard Medical School, US) to discuss the latest findings from the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure trial (ARISE-HF, Applied Therapeutics, Inc) (NCT04083339).This phase 3 multicenter, randomized,… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic